Embolization Coils Market
Medical Device

Embolization Coils Market is estimated to grow at a CAGR of 4.3% during 2022–2028.

In the healthcare industry, embolization coils are used to treat brain aneurysms and cardiac aneurysms, and other blood-related conditions. This is used as an alternative to surgery embolization to cut the supply of blood to the tumor. It is used to treat various types of diseases such as liver cancer, kidney cancer, aortic artery disorders, neuroendocrine tumors, peripheral vascular diseases, and others.

Terumo Corporation and Medtronic – Notable Market Players in Embolization Coils Market     

Key driving factors include an Increase in the Incidence of Cancer cases and a Rise in Patient preference for minimally invasive procedures and a surge in the incidence of Hypertension, Obesity, Smoking, and Alcoholism. High costs of embolization coils and related products, and various product recalls are likely to create a negative impression and are restraining the market growth.

The Embolization coils market is majorly comprised of top players involving Terumo Corporation, Medtronic plc, Boston Scientific Corporation, Stryker Corporation, KANEKA CORPORATION, MicroPort Scientific Corporation, Penumbra, Inc, Cook Medical LLC, Johnson & Johnson Services, Inc., Shape Memory Medical INC, among others.

The companies listed above are implementing various strategies such as product launches, acquisitions, mergers, and partnerships, which have resulted in the company’s growth and, in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.

Below is the list of the growth strategies done by the players operating in the Embolization Coils market:

 

        Year News
Jan-2019 Terumo Announces Novel Intrasaccular Aneurysm Treatment Device Receives FDA PMA Approval
May-2022 FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical
Dec-2019 Kaneka releases a new coil for embolization of brain aneurysms
May-2022  MicroPort NeuroTech Completes First Implantation of Numen Coil Embolization System in the U.S.
May-2019 Shape Memory Medical gets FDA nod for Impede-FX embolization plug
 Jun-2022 Kaneka releases a new coil for embolization of brain aneurysms
Aug-2022 Boston Scientific Corporation BSX announced the acquisition of Obsidio, Inc. It is a privately held company is the renowned developer of the FDA-authorized Gel Embolic Material (GEM) technology.